Physician profile
Lucius Craig
NPI 1457309098
$7,642.21
in general payments reported to CMS, 2019-2025
12 companies · $244 in 2025
The $244 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,744 · 2020: $14.47 · 2021: $99.02 · 2022: $2,427 · 2023: $57.50 · 2024: $56.11 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,082.74 | 2019-2024 | T2, Gamma |
| Zimmer Biomet Holdings, INC. | $197.66 | 2025 | Comprehensive Shoulder System |
| Heron Therapeutics, INC. | $109.68 | 2021-2022 | |
| Bioventus LLC | $65.40 | 2021-2023 | Exogen Ultrasound Bone Healing System |
| Pacira Pharmaceuticals Incorporated | $45.11 | 2022-2023 | Exparel, Zilretta, Iovera |
| Innovation Technologies INC | $29.74 | 2025 | Irrisept |
| Smith+Nephew, INC. | $27.60 | 2022 | |
| Kerecis Limited | $25.84 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Solventum Corporation | $16.91 | 2025 | Activ.A.C. |
| Baudax Bio INC. | $14.47 | 2020 | |
| Osteoremedies, LLC | $14.12 | 2024 | Osteoboost Select 10cc, Biowash Surgical Irrigation, Biobrush |
| Abbvie INC. | $12.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucius Craig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.